HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E W Humke Selected Research

DMUC5754A

11/2016Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E W Humke Research Topics

Disease

2Ovarian Neoplasms (Ovarian Cancer)
01/2018 - 11/2016
1Neoplasms (Cancer)
11/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2016
1Inflammation (Inflammations)
09/2001

Drug/Important Bio-Agent (IBA)

2Immunoconjugates (Immunoconjugate)IBA
01/2018 - 11/2016
2PlatinumIBA
01/2018 - 11/2016
1liposomal doxorubicin (Doxil)FDA Link
01/2018
1lifastuzumab vedotinIBA
01/2018
1CR 6IBA
11/2016
1AntigensIBA
11/2016
1DMUC5754AIBA
11/2016
1Proteins (Proteins, Gene)FDA Link
09/2001